About Inner Mongolia Baogang Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Inner Mongolia Baogang Hospital
During the past decade, Inner Mongolia Baogang Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Inner Mongolia Baogang Hospital" #1 sponsor was "Peking Union Medical College Hospital" with 2 trials, followed by "Angde Biotech Pharmaceutical Co., Ltd." with 1 trials
sponsored, "Bayer" with 1 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored and "Berry Genomics Co., Ltd."
with 1 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Inner Mongolia Baogang Hospital"
#1 collaborator was "Baotou Cancer Hospital" with 1 trials as a collaborator, "Baotou Central Hospital" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator, "First Affiliated Hospital of Jinan University" with 1 trials as a collaborator and "Fudan University" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Inner Mongolia Baogang Hospital
According to Clinical.Site data, the most researched conditions in "Inner Mongolia Baogang Hospital" are
"Stroke" (3 trials), "Acute Ischemic Stroke" (2 trials), "Abnormal Mucus Secretions" (1 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "Inner Mongolia Baogang Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Inner Mongolia Baogang Hospital
Most popular intervention types in "Inner Mongolia Baogang Hospital" are "Drug" (13 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (2 trials), "Ambroxol hydrochloride 30 mg" (1 trials), "Aspirin" (1 trials), "Aspirin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials) and "Asprin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Inner Mongolia Baogang Hospital
The vast majority of trials in "Inner Mongolia Baogang Hospital" are
14 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Inner Mongolia Baogang Hospital
Currently, there are NaN active trials in "Inner Mongolia Baogang Hospital".
1 are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Inner Mongolia Baogang Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Inner Mongolia Baogang Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".